WVE insider transaction filings
Wave Life Sciences, Inc. — 45 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-13. Screen WVE transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-13 | 4 | Wagner Heidi L — Director | Option exercise (M): 7,000 @ $5.97 · Sale (S): 7,000 @ $6.01 · Option exercise (M): 7,000 (derivative) @ $0 | EDGAR |
| 2026-08-13 | 4 | Tan Aik Na — Director | Sale (S): 432 @ $6.01 | EDGAR |
| 2026-08-13 | 4 | TAKANASHI KEN — Director | Sale (S): 3,864 @ $6.01 | EDGAR |
| 2026-08-13 | 4 | Rawcliffe Adrian — Director | Sale (S): 12,700 @ $5.29 | EDGAR |
| 2026-03-30 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 4,954,558 @ $6.06 · Purchase (P): 351,224 @ $6.38 · Purchase (P): 2,495,623 @ $6.43 · Purchase (P): 971,091 @ $6.50 | EDGAR |
| 2026-03-26 | 4 | TAKANASHI KEN — Director | Conversion (C): 3,901,348 @ $0 · Conversion (C): 3,901,348 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Francis Chris — See Remarks | Option exercise (M): 17,900 @ $3.87 · Sale (S): 17,900 @ $15.09 · Option exercise (M): 15,294 @ $4.75 · Sale (S): 15,294 @ $15 · Option exercise (M): 17,900 (derivative) @ $0 · Option exercise (M): 15,294 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Moran Kyle — Chief Financial Officer | Grant/award (A): 45,625 @ $0 · Sale (S): 3,588 @ $13.45 · Grant/award (A): 273,750 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | BOLNO PAUL — President and CEO, Director | Grant/award (A): 165,000 @ $0 · Sale (S): 10,480 @ $13.45 · Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Francis Chris — See Remarks | Grant/award (A): 38,750 @ $0 · Sale (S): 1,883 @ $13.45 · Grant/award (A): 232,500 (derivative) @ $0 | EDGAR |
| 2026-02-11 | 4 | Vargeese Chandra — See Remarks | Grant/award (A): 45,625 @ $0 · Sale (S): 3,228 @ $13.45 · Grant/award (A): 273,750 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | Francis Chris — See Remarks | Option exercise (M): 9,375 @ $3.14 · Sale (S): 8,080 @ $15.92 · Sale (S): 1,295 @ $16.70 · Option exercise (M): 9,375 (derivative) @ $0 | EDGAR |
| 2025-12-15 | 4 | GSK plc — 10% owner | Purchase (P): 1,470,000 @ $19 | EDGAR |
| 2025-12-10 | 4 | Wagner Heidi L — Director | Option exercise (M): 7,000 @ $5.97 · Sale (S): 7,000 @ $13 · Option exercise (M): 7,000 @ $5.97 · Sale (S): 7,000 @ $14 · Option exercise (M): 14,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Tan Aik Na — Director | Sale (S): 7,494 @ $12.75 · Sale (S): 7,494 @ $15 · Option exercise (M): 32,230 @ $5.37 · Sale (S): 15,000 @ $12.75 · Sale (S): 17,230 @ $15 · Option exercise (M): 45,000 @ $4.58 · +10 more | EDGAR |
| 2025-12-10 | 4 | Francis Chris — See Remarks | Option exercise (M): 28,125 @ $3.14 · Sale (S): 28,125 @ $14.50 · Option exercise (M): 107,400 @ $3.87 · Sale (S): 107,400 @ $14.56 · Option exercise (M): 45,882 @ $4.75 · Sale (S): 45,882 @ $14.50 · +17 more | EDGAR |
| 2025-12-10 | 4 | Moran Kyle — Chief Financial Officer | Option exercise (M): 60,000 @ $2.83 · Sale (S): 60,000 @ $13.20 · Option exercise (M): 100,000 @ $3.14 · Sale (S): 50,000 @ $15 · Sale (S): 50,000 @ $13.20 · Option exercise (M): 50,000 @ $4.75 · +10 more | EDGAR |
| 2025-12-10 | 4 | Verdine Gregory L. — Director | Sale (S): 12,020 @ $13.09 · Sale (S): 7,980 @ $14.05 | EDGAR |
| 2025-12-10 | 4 | Rawcliffe Adrian — Director | Option exercise (M): 42,000 @ $5.97 · Sale (S): 42,000 @ $15 · Option exercise (M): 42,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | HENRY CHRISTIAN O — Director | Sale (S): 6,445 @ $12.75 · Option exercise (M): 42,000 @ $5.97 · Sale (S): 42,000 @ $12.75 · Option exercise (M): 15,000 @ $3.50 · Sale (S): 15,000 @ $14.07 · Option exercise (M): 30,000 @ $4.58 · +4 more | EDGAR |
| 2025-12-10 | 4 | CORRIGAN MARK — Director | Sale (S): 9,600 @ $13.09 · Sale (S): 6,515 @ $14.06 | EDGAR |
| 2025-11-14 | 4 | Rawcliffe Adrian — Director | Sale (S): 16,115 @ $6.79 | EDGAR |
| 2025-11-14 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Purchase (P): 1,000 @ $6.69 | EDGAR |
| 2025-08-26 | 4 | BOLNO PAUL — President and CEO, Director | Sale (S): 217,351 @ $10.10 | EDGAR |
| 2025-08-26 | 4 | Verdine Gregory L. — Director | Sale (S): 10,000 @ $10 | EDGAR |
| 2025-08-19 | 4 | Tan Aik Na — Director | Option exercise (M): 21,000 @ $9.13 · Sale (S): 21,000 @ $9.25 · Option exercise (M): 21,000 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | Tan Aik Na — Director | Grant/award (A): 25,400 @ $0 · Grant/award (A): 152,400 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | TAKANASHI KEN — Director | Grant/award (A): 12,700 @ $0 · Grant/award (A): 76,200 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | Wagner Heidi L — Director | Grant/award (A): 12,700 @ $0 · Grant/award (A): 76,200 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | Verdine Gregory L. — Director | Grant/award (A): 12,700 @ $0 · Grant/award (A): 76,200 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | Rawcliffe Adrian — Director | Grant/award (A): 12,700 @ $0 · Grant/award (A): 76,200 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | RA CAPITAL MANAGEMENT, L.P. — Director, 10% owner RA Capital Healthcare Fund LP — Director, 10% owner Kolchinsky Peter — Director, 10% owner Shah Rajeev M. — Director, 10% owner | Grant/award (A): 12,700 @ $0 · Grant/award (A): 76,200 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | HENRY CHRISTIAN O — Director | Grant/award (A): 12,700 @ $0 · Sale (S): 9,670 @ $8.81 · Grant/award (A): 76,200 (derivative) @ $0 | EDGAR |
| 2025-08-13 | 4 | CORRIGAN MARK — Director | Grant/award (A): 12,700 @ $0 · Grant/award (A): 76,200 (derivative) @ $0 | EDGAR |
| 2025-08-07 | 4 | TAKANASHI KEN — Director | Sale (S): 4,872 @ $8.75 | EDGAR |
| 2025-08-07 | 4 | Tan Aik Na — Director | Sale (S): 1,127 @ $8.75 | EDGAR |
| 2025-06-13 | 4 | Verdine Gregory L. — Director | Sale (S): 30,000 @ $6.95 | EDGAR |
| 2025-03-21 | 4 | HENRY CHRISTIAN O — Director | Option exercise (M): 10,500 @ $9.13 · Sale (S): 10,500 @ $9.77 · Option exercise (M): 10,500 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | BOLNO PAUL — President and CEO, Director | Option exercise (M): 169,025 @ $2.48 · Sale (S): 169,025 @ $9.57 · Option exercise (M): 120,966 (derivative) @ $0 · Option exercise (M): 48,059 (derivative) @ $0 | EDGAR |
| 2025-03-07 | 4 | Verdine Gregory L. — Director | Option exercise (M): 133,000 @ $2.48 · Option exercise (M): 133,402 @ $2.48 · Option exercise (M): 133,000 (derivative) @ $0 · Option exercise (M): 133,402 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | Vargeese Chandra — See Remarks | Option exercise (M): 91,754 @ $2.48 · Option exercise (M): 16,422 (derivative) @ $0 · Option exercise (M): 75,332 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Moran Kyle — Chief Financial Officer | Grant/award (A): 42,000 @ $0 · Grant/award (A): 252,000 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | BOLNO PAUL — President and CEO, Director | Grant/award (A): 121,000 @ $0 · Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Francis Chris — See Remarks | Grant/award (A): 25,000 @ $0 · Grant/award (A): 151,000 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Vargeese Chandra — See Remarks | Grant/award (A): 37,000 @ $0 · Grant/award (A): 224,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Wave Life Sciences, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-07-30 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-26 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-05-18 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-28 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-21 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-15 | 8-K | 1.01 — Entry into a Material Definitive Agreement 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-26 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-26 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-02 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-12 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=WVE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →